REGISTERED NUMBER: 12215708 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

VANGUARD MEDICAL DEVICES LIMITED

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

3

DIRECTOR:

Ulrike Marczak

SECRETARY:

JTC (UK) Limited

REGISTERED OFFICE:

The Scalpel

18th Floor,

52 Lime Street

London

EC3M 7AF

REGISTERED NUMBER:

12215708 (England and Wales)

AUDITORS:

Ad Valorem Audit Services Limited

Chartered Certified Accountants & Statutory

Auditors

2 Manor Farm Court

Old Wolverton Road

Old Wolverton

Milton Keynes

Buckinghamshire

MK12 5NN

FIXED ASSETS

Tangible assets

4

2,309

1,228

CURRENT ASSETS

Stocks

16,969

-

Debtors

5

171,592

26,463

Cash at bank

69,131

8,128

257,692

34,591

CREDITORS

Amounts falling due within one year

6

515,606

148,798

NET CURRENT LIABILITIES

(257,914

)

(114,207

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(255,605

)

(112,979

)

CREDITORS

Amounts falling due after more than one year

7

1,520,827

1,394,547

NET LIABILITIES

(1,776,432

)

(1,507,526

)

CAPITAL AND RESERVES

Called up share capital

8

1

1

Retained earnings

(1,776,433

)

(1,507,527

)

SHAREHOLDERS' FUNDS

(1,776,432

)

(1,507,526

)

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 May 2026 and were signed by:

Ulrike Marczak - Director

1.	STATUTORY INFORMATION

Vanguard Medical Devices Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

33% on cost

STOCKS

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FOREIGN CURRENCIES

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

GOING CONCERN

The company made a loss for the year ended 31 December 2025 of £268,906 (2024: £49,337) and had a balance sheet deficiency of £1,776,432 (2024: £1,507,526) at that date and, as a consequence, is dependent upon the support of its parent company to continue as a going concern. These conditions indicate that a material uncertainty exists that may cast doubt on the company's ability to continue as a going concern.

PARENT COMPANY

The immediate parent undertaking of Vanguard Medical Devices LTD is Vanguard AG, a Company incorporated in Germany with registered office at Landsberger Str. 222, 12623 Berlin, Deutschland.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 January 2025

2,152

Additions

1,728

At 31 December 2025

3,880

DEPRECIATION

At 1 January 2025

924

Charge for year

647

At 31 December 2025

1,571

NET BOOK VALUE

At 31 December 2025

2,309

At 31 December 2024

1,228

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

as restated

£

£

Trade debtors

167,441

-

Amounts owed by group undertakings

-

23,985

Other debtors

4,151

2,478

171,592

26,463

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

as restated

£

£

Trade creditors

32,103

1,886

Amounts owed to group undertakings

354,983

-

Taxation and social security

27,660

78,225

Other creditors

100,860

68,687

515,606

148,798

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

as restated

£

£

Amounts owed to group undertakings

1,520,827

1,394,547

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

as restated

£

£

1

Ordinary share

£1

1

1

9.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Zubair Arshad (FCCA, ACA) (Senior Statutory Auditor)

for and on behalf of Ad Valorem Audit Services Limited

10.	RELATED PARTY DISCLOSURES

During the year, the company operated loans with its parent company. The total amount outstanding as at the year-end date was £1,875,810 (2024: £1,370,563), of which £354,983 is included within current liabilities and the remaining £1,520,827 is classified as liabilities due after more than one year. Interest is charged on the loans at a rate of 2.5% per annum.

11.	ULTIMATE CONTROLLING PARTY

Mr Thomas Peter Maier is the controlling party.